MedXY
MedXY
HomeCasesFAQHow to Ask
Case Library

Public Shared Medical Q&A

This directory keeps different languages in one shared archive so search engines can discover the mixed-language corpus together. The filter below is only for browsing convenience.

Filter
AllEnglish简体中文繁體中文日本語한국어EspañolPortuguêsTiếng Việt
Page 8 / 11
en2026-05-12

Flutiform Inhalation Powder

Flutiform Inhalation Powder contains two bronchodilators; if combined with an injection of Dihydroxypropyl Theophylline, this amounts to a total of three bronchodilators. Is thi...

**Conclusion:** The combination of Flutiform (fluticasone propionate/formoterol fumarate) with injectable dihydroxypropyl theophylline is not inherently prohibited by regulatory contraindications, but it requires strict clinical justification, therapeutic d...

ja2026-05-12

ハンタウイルス感染予防

ハンタウイルスのヒトからヒトへの感染にはどのような特徴があり、どのように予防することができるのでしょうか

## ハンタウイルスのヒト-ヒト感染:特徴と予防 ### はじめに ハンタウイルス感染症のうち、特に**アンデスウイルス (Andes virus, ANDV)** は、他のハンタウイルスとは異なり、ヒト-ヒト感染が確認されている点で特異的です。本稿では、その疫学的特徴と予防対策について、エビデンスに基づき解説します。 ### ヒト-ヒト感染の特徴 #### 1. 原因ウイルスと地理的分布 - **アンデスウイルス (ANDV)** が、ハンタウイルスの中で唯一、ヒト-ヒト感染が報告されている病原体です[1]...

en2026-05-11

Hypocalcemia Hypomagnesemia Hypokalemia

In cases where hypocalcemia, hypomagnesemia, and hypokalemia coexist, magnesium supplementation may facilitate the correction of the hypokalemia; however, I am concerned that it...

## Clinical Evidence & Efficacy The concern that magnesium supplementation might adversely affect hypocalcemia in the setting of coexisting hypomagnesemia, hypocalcemia, and hypokalemia is **not supported by the retrieved evidence**. In fact, the data indic...

vi2026-05-11

Giải thích nguy cơ xương steroid

Làm sao giải thích cho bệnh nhân về nguy cơ chuyển hóa xương khi dùng steroid lâu dài và đưa ra biện pháp phòng ngừa thực tế?

# Hướng dẫn Tư vấn Bệnh nhân về Loãng xương do Glucocorticoid (GIOP) ## Giải thích cho Bệnh nhân về Cơ chế Tác động của Steroid lên Xương ### Ngôn ngữ Dễ hiểu cho Bệnh nhân **"Steroid ảnh hưởng đến xương của bạn như thế nào?"** - **Tác động nhanh chóng**: N...

vi2026-05-11

Phác đồ Atezolizumab-Bevacizumab HCC

Hiệu quả và độ an toàn của phác đồ Atezolizumab-Bevacizumab so với Tremelimumab-Durvalumab trong HCC giai đoạn tiến triển

## Kết luận Dựa trên bằng chứng hiện tại, phác đồ **Atezolizumab-Bevacizumab** (Atezo-Bev) cho thấy hiệu quả vượt trội hơn so với **Tremelimumab-Durvalumab** (STRIDE) về cả thời gian sống thêm toàn bộ (OS) và chất lượng cuộc sống, trong khi STRIDE có hồ sơ...

vi2026-05-11

Chiến lược điều trị ung thư gan

Chiến lược điều trị hàng đầu và các điểm cần cân nhắc của ung thư biểu mô tế bào gan là gì?

# Chiến lược điều trị hàng đầu và các điểm cần cân nhắc của ung thư biểu mô tế bào gan (HCC) **Kết luận**: Chiến lược điều trị HCC phụ thuộc vào giai đoạn BCLC, chức năng gan (Child-Pugh) và tình trạng toàn thân (ECOG PS), trong đó phác đồ miễn dịch kết hợp...

vi2026-05-11

Tác dụng phụ dupilumab liều cao

Tác dụng không mong muốn của dupilumab liều cao là gì?

Dựa trên các tài liệu đã truy xuất, không có dữ liệu cụ thể nào về tác dụng không mong muốn của **liều cao dupilumab** (cao hơn liều chuẩn). Tất cả các dữ liệu về tính an toàn đều được báo cáo dựa trên các phác đồ liều chuẩn đã được phê duyệt cho từng chỉ đ...

ja2026-05-11

MDA5抗体陽性皮膚筋炎治療

72歳の女性患者が、急速進行性間質性肺疾患(RP-ILD)を合併したMDA5抗体陽性皮膚筋炎(MDA5-DM)と診断されました。現在、高用量ステロイド、シクロホスファミド、タクロリムス、IVIGパルス療法、および血漿交換による治療を受けています。血漿交換を行う目的で右下肢に大腿静脈カテーテルが留置されましたが、今夕になって右下肢に浮腫が出現しました。そ...

結論:本症例では、血漿交換用に留置された大腿静脈カテーテルに起因する **カテーテル関連深部静脈血栓症 (Catheter-Related Deep Vein Thrombosis, CRT)** が最も可能性の高い原因です。 --- ## 鑑別診断 ### 1. カテーテル関連深部静脈血栓症 (CRT) — 最優先 **根拠**: - 大腿静脈カテーテル留置という明確な危険因子が存在します。 - カテーテル関連血栓症 (CRT) は、上肢静脈血栓症 (UEDVT) と比較して下肢深部静脈血栓症 (LEDVT...

zh-CN2026-05-11

二甲双胍与阿司匹林

二甲双胍与阿司匹林

**Drug Interaction Safety Check: Metformin + Aspirin** **Interaction Risk:** Potential (Moderate clinical significance) **Mechanism:** Aspirin may enhance the hypoglycemic effect of metformin. High doses of salicylates (e.g., >2 g/day aspirin) can have intr...

ja2026-05-11

ハンタウイルス治療法とワクチン開発

ハンタウイルスに感染した場合、現在どのような治療法が利用可能ですか?また、現在開発中のワクチンはありますか?

ハンタウイルス感染症(特にハンタウイルス心肺症候群および腎症候性出血熱)に対する現時点での治療は、主に**対症療法(支持療法)**が中心であり、原因療法や予防ワクチンは確立されていません。 ## 現在利用可能な治療法 ### 1. 支持療法(標準治療) 重症例、特にハンタウイルス心肺症候群(HCPS)においては、早期の集中治療室(ICU)管理が予後を大きく左右します。 - **呼吸管理**: - **酸素療法**: 低酸素血症に対する第一選択。 - **人工呼吸管理**: 急性呼吸窮迫症候群(ARDS)に対す...

es2026-05-11

Hantavirus Subtypes Transmission

What Hantavirus subtypes currently exist, and what are their respective modes of transmission and epidemiological characteristics?

# Hantavirus Subtypes: Transmission and Epidemiological Characteristics Hantaviruses are segmented, single-stranded RNA viruses belonging to the *Hantaviridae* family (formerly *Bunyaviridae*), with over 20 genotypes identified in the Americas alone [2]. Th...

es2026-05-11

Hantavirus Transmission

Has Hantavirus been confirmed to be transmissible from person to person? Is this true?

# Hantavirus Person-to-Person Transmission: Evidence Assessment ## Key Distinction by Virus Genotype The answer depends critically on **which hantavirus genotype** is being discussed. The evidence clearly differentiates between **Andes virus (ANDV)** and al...

en2026-05-10

Ammonia Intoxication Hepatic Encephalopathy

The core mechanisms of the ammonia intoxication hypothesis of hepatic encephalopathy, and the pathophysiological processes of the false neurotransmitter hypothesis.

## Hepatic Encephalopathy: Core Mechanisms of the Ammonia Intoxication and False Neurotransmitter Hypotheses ### Ammonia Intoxication Hypothesis Ammonia is the most extensively investigated neurotoxin in hepatic encephalopathy (HE) pathogenesis. The central...

en2026-05-10

Dual Antiplatelet Therapy

A patient on long-term dual antiplatelet therapy (aspirin plus clopidogrel) is scheduled to undergo laparoscopic cholecystectomy. Regarding the preoperative bridging strategy, i...

**Conclusion**: For a patient on dual antiplatelet therapy (DAPT) undergoing laparoscopic cholecystectomy, the 2022 ACCP guidelines do **not** recommend LMWH bridging for antiplatelet agents. The perioperative strategy focuses on timing of antiplatelet cess...

ja2026-05-09

肝腎同時移植後治療経過

肝腎同時移植から18ヶ月が経過した現在、本患者はタクロリムス、ミコフェノール酸モフェチル、プレドニゾン、およびアムロジピンによる治療を受けている。肝機能は正常であり、腎機能も安定しており、クレアチニン値は130〜140の範囲で推移している。本患者には20年間の高血圧の既往があり、現在の血圧は約132/80と良好にコントロールされている。総コレステロール...

**結論:スタチン療法の開始が推奨される。** 本症例は、肝腎同時移植後、タクロリムスベースの免疫抑制療法下にある患者であり、頸動脈プラークを有する。脂質低下療法の適応は、移植後患者における心血管疾患 (CVD) リスク管理の観点から支持される。 --- ## 治療適応の根拠 ### 1. 移植後患者における脂質管理のガイドライン推奨 - **肝移植後 (LT) 患者**: AASLDガイドラインは、心血管リスク因子(年齢、糖尿病、高血圧、CKD、喫煙、家族歴、LDL上昇)に基づく層別化アプローチを推奨してい...

zh-CN2026-05-09

肝肾联合移植后随访

肝肾联合移植后18个月,目前服他克莫司,米芙,强的松,络活喜治疗中,肝功能正常,肾功能稳定,肌酐在130-140上下,有高血压病史20年,目前血压控制可,血压132/80左右,总胆固醋不高,但低密度2.8,劲动脉有小的斑块,其他所有指标均正常,患者无其他病史,这种情况需要加服他汀药吗?

**结论:根据现有指南和检索到的证据,该患者应考虑启动他汀类药物治疗。** 该患者为肝肾联合移植术后18个月,存在明确的动脉粥样硬化性心血管疾病(ASCVD)风险因素:高血压病史、慢性肾功能不全(eGFR约40-50 mL/min/1.73m²,对应CKD G3b期)、颈动脉斑块,且低密度脂蛋白胆固醇(LDL-C)为2.8 mmol/L(约108 mg/dL),已超过移植后患者的推荐目标值。 --- ### 治疗策略分析 #### 1. 启动他汀治疗的指征与证据 - **移植后患者的高危状态**:实体器官移植...

en2026-05-08

Norepinephrine Infusion Preparation

How should a norepinephrine infusion be prepared for a 90 kg obese patient?

### Drug Nomenclature - **Generic Name (INN)**: Norepinephrine (also known as Noradrenaline) - **Drug Class**: Sympathomimetic amine; direct-acting alpha-1 and beta-1 adrenergic receptor agonist - **ATC Code**: C01CA03 ### Preparation of Norepinephrine Infu...

ja2026-05-08

高血圧患者の生活習慣介入

高血圧患者は、日常生活において、食事および生活習慣のどのような具体的な側面に介入を通じて取り組むべきでしょうか。

高血圧患者に対する生活習慣介入は、薬物療法の効果を高め、心血管リスクを低減するための基盤であり、すべての患者に推奨されます[1][6][7]。以下、食事と生活習慣の各側面について、エビデンスに基づく具体的な介入内容を提示します。 **以下の図は、高血圧管理における主要な生活習慣介入の概要を示しています。** ![【image_category: FLOWCHART/Lifestyle Modification Infographic】Lifestyle Modification Infographic](ht...

en2026-05-08

Hyperthyroidism Atrial Fibrillation

For a patient with a strong suspicion of hyperthyroidism presenting with rapid atrial fibrillation, what injectable medication should be used to control the ventricular rate?

For a patient with suspected hyperthyroidism presenting with rapid atrial fibrillation (AF), the preferred injectable medication for acute ventricular rate control is a **beta-blocker**, specifically **intravenous propranolol** or **intravenous esmolol**. *...

en2026-05-08

Multiple Myeloma Drug Sequence

In patients with multiple myeloma, the sequence of administration for lenalidomide, dexamethasone, bortezomib, and daratumumab is as follows?

For patients with newly diagnosed multiple myeloma (NDMM) eligible for autologous stem cell transplant (ASCT), the standard quadruplet regimen is **Daratumumab + Bortezomib + Lenalidomide + Dexamethasone (D-VRd)**. Based on the retrieved prescribing informa...

en2026-05-08

Late-Night Health Effects

Which organs in the body are damaged by frequent late-night hours, and are there any ways to mitigate the associated health risks?

# Health Impact of Frequent Late-Night Hours and Mitigation Strategies ## Organ Systems Affected by Circadian Disruption Frequent late-night hours—particularly shift work or chronic sleep-wake misalignment—disrupts the central circadian clock in the suprach...

en2026-05-07

Statin Muscle Symptoms CK Elevation

Statin-associated muscle symptoms pathophysiology mechanisms CK elevation without myalgia

## Statin-Associated Muscle Symptoms: Pathophysiology, Mechanisms, and CK Elevation Without Myalgia ### Pathophysiology and Mechanisms The exact molecular mechanism of statin-associated muscle symptoms (SAMS) remains incompletely understood, with evidence s...

zh-CN2026-05-07

Atorvastatin CK Level Increase

Following the administration of atorvastatin, the patient's creatine kinase (CK) levels rose to three times the upper limit of normal; however, no significant symptoms of myalgi...

**结论:对于无症状性CK升高至3倍正常上限,不建议立即停用阿托伐他汀,但需进行系统性评估并排除继发原因。** --- ## 临床评估与处理路径 ### 1. 初始评估(排除继发原因) 根据2026 ACC/AHA血脂管理指南,对于所有疑似他汀相关肌肉症状的患者,评估应包括排查继发原因[1]。无症状性CK升高需考虑以下因素: - **剧烈体力活动**:近期运动史是CK升高的最常见非病理性原因[3] - **甲状腺功能减退**:未控制的甲减增加他汀相关肌病风险[1][2] - **慢性肾脏病**:肾功能不全影响...

en2026-05-07

Liver Cirrhosis PT APTT Causes

Patient with liver cirrhosis, what causes a PT of 16 seconds and an APTT of 70?

## Differential Diagnosis of Prolonged PT and aPTT in Liver Cirrhosis In a patient with liver cirrhosis, a PT of 16 seconds (prolonged) and an aPTT of 70 seconds (markedly prolonged) requires systematic evaluation. While liver disease is the most likely eti...

en2026-05-07

Luminal A Breast Cancer Diagnosis

40 years old and have been diagnosed with Luminal A breast cancer (T1bN0M0), with a Ki-67 index of 5% and a 21-gene assay Recurrence Score (RS) of 14.88. Post-surgery, chemother...

## Clinical Evidence & Prognostic Context ### Disease Classification & Risk Stratification Your case represents a highly favorable prognostic profile within the breast cancer spectrum. Based on the retrieved evidence, the key determinants are: **TNM Stage**...

Previous
8 / 11
1…67891011
Next